BDNF and infarction: A recent study has shown that using genetically modified MSCs to over-express BDNF mitigated hypoxic ischemic (HI) deficit by reducing brain infarct, preventing apoptosis, and reducing astrogliosis and inflammatory responses in a rat model of severe neonatal HI brain injury [25].